Serum adenosine deaminase activity and its isoenzyme pattern in patients with systemic lupus erythematosus

Clinical and Experimental Rheumatology

Volumn 16, Issue 5, 1998, Pages 583-586

  Stancikova M ^a   Lukac J ^a   Istok, R ^a   Cristalli, G ^b,c   Rovensky, J ^a,c  

^a NATIONAL INSTITUTE OF RHEUMATIC DISEASES   (Slovakia)

^b UNIVERSITY OF CAMERINO   (Italy)

^c Department of Medicine ^*

Author keywords

Adenosine deaminase; Disease activity; Isoenzyme; Systemic lupus erythematosus

Indexed keywords

ADENOSINE DEAMINASE; ISOENZYME;

ADOLESCENT; ADULT; ARTICLE; DISEASE ACTIVITY; DRUG BLOOD LEVEL; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PURINE METABOLISM; SPECTROPHOTOMETRY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADENOSINE DEAMINASE; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; ISOENZYMES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 0031677792     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. HIRSCHHORN R, RATECH H: Isoenzymes of adenosine deaminase. In RATTAZZI MC, SCANDALIA JG, WHITT GS (Eds.): Isoenzymes: Current Topics in Biological and Medical Research, Vol. 4, NY, Alan R. Liss 1980:132-57.
2. RATECH H, MARTINIUK F, BORER WZ, RAPPOPORT H: Differential expression of adenosine deaminase isoenzymes in acute leukemia. Blood 1988; 72: 1627-32.
3. UNGERER JPJ, OOSTHUIZEN HM, BISSBORT SH, VERMAAK WJH: Serum adenosine deaminase: Isoenzymes and diagnostic application. Clin Chem 1992; 38: 1322-6.
4. GAKIS C: Adenosine deaminase (ADA) isoenzymes ADA1 and ADA2: Diagnostic and biological role. Eur Respir J 1996; 9: 632-3.
5. ZUCKERMAN SH, OLSON JM, DOUGLAS SD: Adenosine deaminase activity during in vitro culture of human peripheral blood monocytes and pulmonary alveolar macrophages. Exp Cell Res 1980; 129: 281-7.
6. YUKSEL H, AKOGLU TF: Serum and synovial fluid adenosine deaminase activity in patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Ann Rheum Dis 1988; 47: 492-5.
7. KOIZUMI H, OHKAWARA A: Adenosine deaminase activity in sera of patients with psoriasis, mycosis fungoides and adult T cell leukemia. Acta Derm Venerol (Stockh) 1992; 72: 410-2.
8. MEUNIER P, FILIPE P, EMERIT I, FREITAS J, RODRIGO FG, MANSO C: Adenosine deaminase in progressive systemic sclerosis. Acta Derm Venereol (Stockh) 1995; 75: 297-9.
9. CHIBA S, MATSUMOTO H, MOTOI Y, MIYANO N, KASHIWAGI M: High serum adenosine deaminase activity and its correlation with lymphocyte subsets in myasthenia gravis. J Neurol Sci 1990; 100: 174-7.
10. NALINI G, HARIPRASAD C, CHANDRASE-KARAN AN, POONGUZHALI K: A comparative study of serum deaminases in systemic rheumatic diseases. Br J Rheumatol 1993; 32: 1118-9.
11. CHIBA S, SAITOH M, KASHIWAGI M, KOBAYASHI N, MATSUMOTO H: Isozyme analysis of the high serum adenosine deaminase activity in patients with myasthenia gravis. Intern Med 1995; 34: 81-4.
12. UNGERER JPJ, OOSTHUIZEN HM, RETIEF JH, BISSBORT SH: Significance of adenosine deaminase activity and its isoenzymes in tuberculous effusions. Chest 1994; 106; 33-7.
13. 2 is a marker for human immunodeficiency virus-1 seroconversion. Am J Hematol 1991; 37: 152-5.
14. STEINBERG AD, KLINMAN DM: Pathogenesis of systemic lupus erythematosus. Rhem Dis Clin North Am 1989; 14: 25-9.
15. SAMSONOV MY, TILZ GP, EGOROVA O, et al.: Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus. Lupus 1995; 4: 29-32.
16. SUZUKI H, TAKEMURA H, KASHIWAGI H: Interleukin-1 receptor antagonist in patients with active systemic lupus erythematosus. Enhanced production by monocytes and correlation with disease activity. Arthritis Rheum 1995; 38:1055-9.
17. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for classification of SLE. Arthritis Rheum 1982; 25: 1271-77.
18. VITALI C, BENCIVELLI W, ISENBERG DA: Disease activity in systemic lupus erythematosus: Report of the Consensus Study Group of the European Workshop for Rheumatology Research II. Identification of the variables of disease activity and their use in the development of an activity score. Clin Exp Rheumatol 1992; 10: 541-7.
19. GIUSTI G: Adenosine deaminase. In BERGMAYER HU (Ed.): Methods of Enzymatic Analysis, Vol. 2, 2nd ed., New York, Academic Press 1974: 1092-9.
20. HARTWICK R, JEFFRIES A, KRSTULOVIC A, BROWN PR: An optimized assay for adenosine deaminase using reverse phase high pressure liquid chromatography. J Chromat Sci 1978; 16: 427-35.
21. MURAOKA T, KATSURAMAKI T, SHIRAISHI H, YOKOYAMA MM: Automated enzymatic measurement of adenosine deaminase isoenzyme activities in serum. Anal Biochem 1990; 187: 268-72.
22. RATECH H, HIRSCHORN R: Serum adenosine deaminase in normals and in a patient with adenosine deaminase deficient-severe combined immunodeficiency. Clin Chim Acta 1981; 115: 341-7.
23. NIEDZWICKI JG, LIOU C, ABERNETHY DR, et al.: Adenosine deaminase isoenzymes of the opossum Dipephis virginiana: Initial chromatographic and kinetic studies. Comp Biochem Physiol 1995; 111B: 291-8.
24. YOKAYAMA MM, TSUBOI I: Adenosine deaminase isoenzymes and HIV/HTLV-1 infections. J Nat Cancer Inst 1988; 80: 698-704.
25. HUBER C, BATCHELOR JR, FUCHS D et al.: Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 1984; 160: 310-6.
26. REIBNEGGER G, EGG D, FUCHS D et al.: Urinary neopterin reflects clinical activity in patients with rheumatoid arthritis. Arthritis Rheum 1986; 29: 1063-70.
27. FUCHS D, HAUSEN A, REIBNEGGER G et al.: Neopterin as a marker for activated cell-mediated immunity: Application in HIV infection, Immunol Today 1988; 9: 150-5.
28. JACKS C, CALL GM, NATION AGE, ORATE ERR, CONNATE A: Serum and pleural adenosine demeans activity. Correct interpretation of the findings. Chest 1991; 99: 1555.